ASSOCIATION OF PREOPERATIVE HBA1C LEVEL WITH STERNAL WOUND INFECTION IN DIABETIC PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFTING

Main Article Content

Yasir Naseem
Faiq Ahmed Khan

Keywords

HbA1c, diabetes mellitus, CABG, sternal wound infection, postoperative infection.

Abstract

Background: Sternal wound infection (SWI) is a serious postoperative complication after coronary artery bypass grafting (CABG), particularly in diabetic patients. Poor glycemic control may delay wound healing and increase infection risk.


Objective: This study aimed to compare the frequency of sternal wound infection in diabetic patients with normal and raised HbA1c levels after CABG.


Methods: A descriptive case series was conducted at the Department of Adult Cardiac Surgery, AFIC/NIHD, Rawalpindi, from 30 April 2019 to 1 November 2019. A total of 370 diabetic patients undergoing elective CABG were included and divided into two equal groups: 185 patients with normal HbA1c and 185 patients with raised HbA1c. Patients were followed for 21 postoperative days for evidence of sternal wound infection. Data were analyzed using SPSS version 23, and p ≤ 0.05 was considered significant. Results: The overall frequency of sternal wound infection was 5.13% (19/370). Infection occurred in 4 patients (2.16%) with normal HbA1c and 15 patients (8.10%) with raised HbA1c. The difference was statistically significant (p = 0.001). The highest infection rate was observed in patients with HbA1c ≥ 8% (21.42%).


Conclusion: Raised HbA1c is significantly associated with a higher frequency of sternal wound infection after CABG in diabetic patients. Preoperative HbA1c assessment and glycemic optimization may help reduce postoperative wound complications.


 

Abstract 0 | Pdf Downloads 0

References

1. International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels: International Diabetes Federation; 2021.
2. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes. N Engl J Med. 1998;339(4):229 234.
3. Kannel WB, McGee DL. Diabetes and cardiovascular disease: The Framingham study. JAMA. 1979;241(19):2035 2038.
4. Farkouh ME, Domanski M, Sleeper LA, et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012;367(25):2375 2384.
5. Carson JL, Scholz PM, Chen AY, Peterson ED, Gold J, Schneider SH. Diabetes mellitus increases short term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol. 2002;40(3):418 423.
6. Ata A, Lee J, Bestle SL, Desemone J, Stain SC. Postoperative hyperglycemia and surgical site infection in general surgery patients. Arch Surg. 2010;145(9):858 864.
7. American Diabetes Association Professional Practice Committee. Standards of care in diabetes—2024. Diabetes Care. 2024;47(Suppl 1):S1 S350.
8. Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomark Insights. 2016;11:95 104.
9. Loop FD, Lytle BW, Cosgrove DM, et al. Sternal wound complications after isolated coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1990;99(1):148 156.
10. Bryan CS, Yarbrough WM. Preventing deep wound infection after coronary artery bypass grafting. Tex Heart Inst J. 2013;40(2):125 139.
11. Fowler VG Jr, O’Brien SM, Muhlbaier LH, Corey GR, Ferguson TB, Peterson ED. Clinical predictors of major infections after cardiac surgery. Circulation. 2005;112(9 Suppl):I358 I365.
12. Ridderstolpe L, Gill H, Granfeldt H, Åhlfeldt H, Rutberg H. Superficial and deep sternal wound complications: Incidence, risk factors and mortality. Eur J Cardiothorac Surg. 2001;20(6):1168 1175.
13. Gatti G, Perrotti A, Reichart D, et al. Glycated hemoglobin and risk of sternal wound infection after isolated coronary surgery. Circ J. 2017;81(1):36 43.
14. Biancari F, Giordano S. Glycated hemoglobin and the risk of sternal wound infection after adult cardiac surgery: A systematic review and meta analysis. Semin Thorac Cardiovasc Surg. 2019;31(3):465 467.
15. Nicolini F, Vezzani A, Fortuna D, et al. Utility of glycated hemoglobin screening in patients undergoing elective coronary artery bypass surgery. Int J Surg. 2018;53:354 359.
16. Lazar HL, McDonnell M, Chipkin SR, et al. The Society of Thoracic Surgeons practice guideline series: Blood glucose management during adult cardiac surgery. Ann Thorac Surg. 2009;87(2):663 669.
17. Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg. 1997;63(2):356 361.
18. Latham R, Lancaster AD, Covington JF, Pirolo JS, Thomas CS Jr. The association of diabetes and glucose control with surgical site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol. 2001;22(10):607 612.
19. Golden SH, Peart Vigilance C, Kao WHL, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care. 1999;22(9):1408 1414.
20. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection. Infect Control Hosp Epidemiol. 1999;20(4):250 278.
21. Halkos ME, Puskas JD, Lattouf OM, et al. Elevated preoperative hemoglobin A1c level is associated with reduced long term survival after coronary artery bypass surgery. Ann Thorac Surg. 2008;86(5):1431 1437.
22. Knapik P, Cieśla D, Filipiak K, Knapik M, Zembala M. Prevalence and clinical significance of elevated preoperative glycosylated hemoglobin in diabetic patients scheduled for coronary artery surgery. Eur J Cardiothorac Surg. 2011;39(4):484 489.
23. Biancari F, Giordano S. Glycated hemoglobin and the risk of sternal wound infection after adult cardiac surgery: A systematic review and meta analysis. Semin Thorac Cardiovasc Surg. 2019;31(3):465 467.
24. Zhao W, Chew NWS, Liew EL, et al. Association between HbA1c and deep sternal wound infection after coronary artery bypass grafting: A systematic review and dose response meta analysis. J Cardiothorac Surg. 2024;19:145.
25. Halkos ME, Lattouf OM, Puskas JD, et al. Elevated preoperative hemoglobin A1c level and outcomes after coronary artery bypass grafting. Ann Thorac Surg. 2008;86(5):1431 1437.
26. The Parisian Mediastinitis Study Group. Risk factors for deep sternal wound infection after sternotomy: A prospective multicenter study. J Thorac Cardiovasc Surg. 1996;111(6):1200 1207.
27. Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125(5):1007 1021.
28. Berríos Torres SI, Umscheid CA, Bratzler DW, et al. Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg. 2017;152(8):784 791.
29. Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70(3):195 283.
30. Engelman R, Shahian D, Shemin R, et al. The Society of Thoracic Surgeons practice guideline series: Antibiotic prophylaxis in cardiac surgery. Ann Thorac Surg. 2007;83(4):1569 1576.